Company news

GSK plc news in 2022

GSK plc's news releases, calls and decks from 2022, newest first.

View company

Board and Committee Changes

December 15, 2022

Jemperli positive trial in endometrial cancer

December 2, 2022

EMA file accepted for momelotinib

December 2, 2022

GSK publishes provisional 2023 dividend dates

November 24, 2022

Blenrep US Update

November 22, 2022

GSK Update: Zejula 2L in US

November 11, 2022

Sanofi-GSK COVID booster vaccine approved by EU

November 10, 2022

DREAMM-3 phase III trial for Blenrep

November 7, 2022

IDMC recommends gepotidacin early efficacy stop

November 3, 2022

GSK RSV vaccine: US FDA Priority Review

November 2, 2022

EMA validates MAA for cabotegravir LA for PrEP

October 28, 2022

EMA accepts GSK RSV older adult vaccine for review

October 28, 2022

GSK announces FDA meeting outcome on daprodustat

October 27, 2022

ContRAst phase III programme for otilimab update

October 27, 2022

Board Committee Changes

October 25, 2022

RSV older adult vaccine submission in Japan

October 21, 2022

Menveo new single-vial approved by US FDA

October 17, 2022

Efficacy results for GSK's older adult RSV vaccine

October 13, 2022

US FDA approves Boostrix maternal immunisation

October 10, 2022

GSK Chief Financial Officer succession

September 26, 2022

US FDA ODAC review of Zejula Phase III NOVA trial

September 22, 2022

GSK and Spero Therapeutics licence for tebipenem

September 22, 2022

GSK provides update on FDA review of daprodustat

September 6, 2022

GSK Board changes

August 24, 2022

Statement: Zantac (ranitidine) litigation update

August 17, 2022

FDA New Drug Application File Acceptance for MMB

August 17, 2022

GSK completes acquisition of Affinivax, Inc.

August 16, 2022

GSK Board change

July 29, 2022

Completion of GSK Share Consolidation

July 19, 2022

Haleon demerger completion and share consolidation

July 18, 2022

Result of General Meeting

July 6, 2022

GSK disclose discontinued operations from Q2 2022

July 5, 2022

GSK completes acquisition of Sierra Oncology

July 1, 2022

GSK files Shingrix 18+ at risk indication in Japan

June 28, 2022

Positive phase III data for GSK's RSV OA vaccine

June 10, 2022

Hardman & Co Life Sciences Research: Long-t...

June 7, 2022

US FDA approval of Priorix

June 6, 2022

Demerger update: Publication of Documents

June 1, 2022

Demerger update: Submission of Documents to FCA

June 1, 2022

GSK to acquire Affinivax, Inc.

May 31, 2022

Further appointments to Designate Haleon Board

May 30, 2022

GSK Cervarix two-dose schedule approved by NMPA

May 27, 2022

Iain Mackay - External Appointment

May 19, 2022

Change of name to GSK plc

May 16, 2022

Daprodustat application accepted for review by FDA

April 19, 2022

GSK agrees to acquire Sierra Oncology for $1.9bn

April 13, 2022

GSK - segment and product sales reporting changes

April 1, 2022

Publication of 2022 AGM Notice

March 28, 2022

FDA update: Cabenuva oral lead-in now optional

March 24, 2022

Issuance of Notes

March 23, 2022

Older news releases →

Calls in 2022

Decks in 2022